Newsletter Archive
-
09.08.25 -- What Life Sciences Companies Can Learn From BMW And Volkswagen
9/8/2025
09/08/25 Life Science Leader Newsletter
-
09.05.25 -- Open Science And A Robust IP Strategy: Life Sciences Can Do Both
9/5/2025
09/05/25 Life Science Leader Newsletter
-
09.05.25 -- New Podcast Episodes: Functional Antibody Screening, Safer Stem Cell Therapies, FDA Fridays
9/5/2025
09/05/25 Life Science Leader Newsletter
-
09.04.25 -- Learn how to enhance productivity in your monoclonal antibody (mAb) capture process
9/4/2025
09/04/25 Life Science Leader Newsletter
-
09.03.25 -- Innovating On The Frontier Of Radiopharmaceuticals
9/3/2025
09/03/25 Life Science Leader Newsletter
-
08.29.25 -- Building An Efficient Biopharma
8/29/2025
08/29/25 Life Science Leader Newsletter
-
08.28.25 -- Advancing ADCs: New Payloads, Faster Timelines, Better Control
8/28/2025
08/28/25 Life Science Leader Newsletter
-
08.27.25 -- Why So Many Biotech Launches Miss Expectations, And How To Fix It
8/27/2025
08/27/25 Life Science Leader Newsletter
-
08.25.25 -- 2025 2H Trends: Regulations, Precision Medicine, Oncology Investment
8/25/2025
08/25/25 Life Science Leader Newsletter
-
08.22.25 -- Developing An In Vivo CAR-T
8/22/2025
08/22/25 Life Science Leader Newsletter